Annual EBIT
-$34.14 M
-$9.53 M-38.70%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual earnings before interest & taxes is -$34.14 million, with the most recent change of -$9.53 million (-38.70%) on December 31, 2023.
- During the last 3 years, ELTX annual EBIT has fallen by -$18.41 million (-117.13%).
- ELTX annual EBIT is now -176.58% below its all-time high of -$12.34 million, reached on December 31, 2019.
Performance
ELTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.70 M
-$11.52 M-160.46%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly earnings before interest & taxes is -$18.70 million, with the most recent change of -$11.52 million (-160.46%) on September 30, 2024.
- Over the past year, ELTX quarterly EBIT has dropped by -$8.04 million (-75.48%).
- ELTX quarterly EBIT is now -521.23% below its all-time high of -$3.01 million, reached on March 31, 2020.
Performance
ELTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$46.62 M
-$8.04 M-20.85%
September 30, 2024
Summary
- As of February 8, 2025, ELTX TTM earnings before interest & taxes is -$46.62 million, with the most recent change of -$8.04 million (-20.85%) on September 30, 2024.
- Over the past year, ELTX TTM EBIT has dropped by -$14.87 million (-46.84%).
- ELTX TTM EBIT is now -1448.65% below its all-time high of -$3.01 million, reached on March 31, 2020.
Performance
ELTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.7% | -75.5% | -46.8% |
| 3 y3 years | -117.1% | -143.3% | -75.3% |
| 5 y5 years | -176.6% | -143.3% | -75.3% |
ELTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.7% | at low | -205.6% | at low | -652.8% | at low |
| 5 y | 5-year | -176.6% | at low | -521.2% | at low | -1448.7% | at low |
| alltime | all time | -176.6% | at low | -521.2% | at low | -1448.7% | at low |
Elicio Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.70 M(+160.5%) | -$46.62 M(+20.9%) |
| Jun 2024 | - | -$7.18 M(-39.1%) | -$38.58 M(+0.9%) |
| Mar 2024 | - | -$11.79 M(+31.8%) | -$38.24 M(+12.0%) |
| Dec 2023 | -$34.14 M(+38.7%) | -$8.95 M(-16.0%) | -$34.14 M(+7.5%) |
| Sep 2023 | - | -$10.66 M(+55.7%) | -$31.75 M(+16.7%) |
| Jun 2023 | - | -$6.84 M(-11.0%) | -$27.21 M(+2.3%) |
| Mar 2023 | - | -$7.69 M(+17.2%) | -$26.60 M(+40.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$24.61 M(-3.6%) | -$6.56 M(+7.2%) | -$18.91 M(+53.1%) |
| Sep 2022 | - | -$6.12 M(-1.8%) | -$12.35 M(+98.2%) |
| Jun 2022 | - | -$6.23 M(+0.6%) | -$6.23 M(+0.6%) |
| Dec 2021 | -$25.52 M(+62.4%) | - | - |
| Mar 2021 | - | -$6.19 M(+105.7%) | -$6.19 M(+105.7%) |
| Dec 2020 | -$15.72 M(+27.4%) | - | - |
| Mar 2020 | - | -$3.01 M | -$3.01 M |
| Dec 2019 | -$12.34 M | - | - |
FAQ
- What is Elicio Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Elicio Therapeutics?
- What is Elicio Therapeutics annual EBIT year-on-year change?
- What is Elicio Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly EBIT year-on-year change?
- What is Elicio Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Elicio Therapeutics?
- What is Elicio Therapeutics TTM EBIT year-on-year change?
What is Elicio Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ELTX is -$34.14 M
What is the all time high annual EBIT for Elicio Therapeutics?
Elicio Therapeutics all-time high annual earnings before interest & taxes is -$12.34 M
What is Elicio Therapeutics annual EBIT year-on-year change?
Over the past year, ELTX annual earnings before interest & taxes has changed by -$9.53 M (-38.70%)
What is Elicio Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ELTX is -$18.70 M
What is the all time high quarterly EBIT for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly earnings before interest & taxes is -$3.01 M
What is Elicio Therapeutics quarterly EBIT year-on-year change?
Over the past year, ELTX quarterly earnings before interest & taxes has changed by -$8.04 M (-75.48%)
What is Elicio Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ELTX is -$46.62 M
What is the all time high TTM EBIT for Elicio Therapeutics?
Elicio Therapeutics all-time high TTM earnings before interest & taxes is -$3.01 M
What is Elicio Therapeutics TTM EBIT year-on-year change?
Over the past year, ELTX TTM earnings before interest & taxes has changed by -$14.87 M (-46.84%)